Chuck Akre

Chuck Akre’s legacy portfolio remains a study in concentrated, high-conviction compounding, with no new positions added in the latest quarter. The fund’s top holdings continue to cluster around a narrow set of businesses with durable margins and strong free cash flow, a hallmark of Akre’s “three-legged stool” approach: a great business, great people, and a great reinvestment opportunity. The absence of turnover in the top ten suggests that management sees little reason to disturb a portfolio that has historically rewarded patience. The most recent 13F shows no material additions or trims among the core names, which diverges sharply from peers who have rotated into cyclical value or short-duration cash proxies. Akre’s legacy book still leans heavily into financial technology and specialty finance, with a notable overweight in companies that generate high returns on tangible capital. This is not a defensive posture; it is a refusal to chase price action. Where other value managers have loosened quality standards to buy cheaper multiples, this portfolio has held firm, accepting lower current yields in exchange for longer-duration earnings growth. One subtle shift is a slight reduction in a long-standing consumer staple position, though the stake remains top-five. The proceeds appear to have been redeployed into an existing industrial holding, reinforcing a bias toward asset-light, fee-based models. The portfolio’s cash position is minimal, and there is no hedging overlay, consistent with Akre’s stated belief that time, not market timing, is the primary driver of returns. For a fund that has rarely traded, the message is unchanged: the best response to an uncertain tape is to own fewer, better businesses and let the balance sheet do the talking.